In patients with AF, the presence of left atrial/left atrial appendage (LA/LAA) thrombus is
related to an increased risk of thromboembolic events. Anticoagulation therapy, either with …

Background Left atrial appendage thrombus (LAAT) is the main cause of cardioembolism in
patients with nonvalvular atrial fibrillation (AF). Emerging evidence indicates that direct oral …

Aims Transoesophageal echocardiography (TOE) is often performed before catheter
ablation or cardioversion to rule out the presence of left atrial appendage thrombus (LAT) in …

Whole blood viscosity (WBV) is considered as a reasonable proxy measure of blood flow,
and it has been investigated in different cohort settings, including in patients with deep …

Atrial fibrillation (AF) is the most common arrhythmia in adults worldwide and represents an
important burden for patients, physicians, and healthcare systems. AF is associated with …

Aims The aim of the study was to evaluate the prevalence of left atrial thrombus (LAT) on
transoesophageal echocardiography (TOE) in patients with atrial fibrillation or atrial flutter …

Left atrial appendage thrombus (LAAT) is a surrogate of thromboembolic events in patients
with nonvalvular atrial fibrillation (NVAF). We aimed to investigate the risk factors for LAAT …

Introduction The left atrium appendage thrombus (LAAT) formation is a complex process. A
CHA2DS2-VASc scale is an established tool for determining the thromboembolic risk and …

Objectives: We attempted to develop more precisely quantified risk models for predicting
cardiogenic stroke risk in non-valvular atrial fibrillation (NVAF) patients. Methods: We …

Background Atrial fibrillation (AF) is the most common type of clinical arrhythmia. An early
diagnosis can be beneficial in the prevention of complications, such as heart failure (HF) …